News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,685 Results
Type
Article (4686)
Company Profile (27)
Press Release (105972)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (40733)
Career Advice (122)
Deals (7027)
Drug Delivery (24)
Drug Development (13263)
Employer Resources (15)
FDA (2503)
Job Trends (3342)
News (61759)
Policy (4271)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (353)
Accelerated approval (7)
Allergies (38)
Alliances (4671)
ALS (35)
Alzheimer's disease (272)
Antibody-drug conjugate (ADC) (79)
Approvals (2672)
Artificial intelligence (63)
Autoimmune disease (45)
Automation (7)
Bankruptcy (53)
Best Places to Work (2905)
BIOSECURE Act (2)
Biosimilars (37)
Biotechnology (16)
Bladder cancer (62)
Brain cancer (9)
Breast cancer (171)
Cancer (1218)
Cardiovascular disease (96)
Career advice (113)
Career pathing (2)
CAR-T (33)
CDC (4)
Celiac Disease (1)
Cell therapy (111)
Cervical cancer (5)
Clinical research (12372)
Collaboration (249)
Company closure (1)
Compensation (145)
Complete response letters (6)
COVID-19 (393)
CRISPR (19)
C-suite (93)
Cystic fibrosis (15)
Data (1708)
Depression (28)
Dermatology (19)
Diabetes (110)
Diagnostics (1133)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (43)
Drug pricing (39)
Drug shortages (2)
Duchenne muscular dystrophy (38)
Earnings (33873)
Editorial (9)
Employer branding (3)
Employer resources (13)
Events (14604)
Executive appointments (113)
FDA (3386)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (216)
Gene editing (41)
Generative AI (5)
Gene therapy (88)
GLP-1 (184)
Government (697)
Grass and pollen (2)
Guidances (298)
Healthcare (3358)
HIV (41)
Huntington's disease (7)
IgA nephropathy (26)
Immunology and inflammation (43)
Immuno-oncology (5)
Indications (49)
Infectious disease (461)
Inflammatory bowel disease (41)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (24)
Interviews (16)
IPO (4491)
IRA (9)
Job creations (554)
Job search strategy (98)
JPM (8)
Kidney cancer (2)
Labor market (32)
Layoffs (122)
Leadership (2)
Legal (678)
Liver cancer (20)
Longevity (3)
Lung cancer (191)
Lymphoma (103)
Machine learning (5)
Management (5)
Manufacturing (114)
MASH (62)
Medical device (2533)
Medtech (2549)
Mergers & acquisitions (2750)
Metabolic disorders (288)
mRNA (20)
Multiple sclerosis (31)
NASH (4)
Neurodegenerative disease (48)
Neuropsychiatric disorders (17)
Neuroscience (509)
NextGen: Class of 2026 (904)
Non-profit (514)
Now hiring (4)
Obesity (106)
Opinion (29)
Ovarian cancer (44)
Pain (28)
Pancreatic cancer (42)
Parkinson's disease (52)
Partnered (4)
Patents (48)
Patient recruitment (61)
Peanut (13)
People (4876)
Pharmaceutical (3)
Pharmacy benefit managers (8)
Phase 1 (2917)
Phase 2 (5228)
Phase 3 (5205)
Pipeline (2637)
Policy (50)
Postmarket research (473)
Preclinical (937)
Press Release (5)
Prostate cancer (68)
Psychedelics (9)
Radiopharmaceuticals (46)
Rare diseases (167)
Real estate (699)
Recruiting (7)
Regulatory (3759)
Reports (15)
Research institute (299)
Resumes & cover letters (16)
Rett syndrome (6)
RNA editing (3)
RSV (24)
Schizophrenia (46)
Series A (26)
Series B (22)
Service/supplier (1)
Sickle cell disease (23)
Special edition (8)
Spinal muscular atrophy (33)
Sponsored (9)
Startups (379)
Stomach cancer (3)
Supply chain (11)
Tariffs (16)
The Weekly (10)
Vaccines (186)
Venture capital (13)
Weight loss (67)
Women's health (16)
Worklife (3)
Date
Last 7 days (150)
Last 30 days (409)
Last 365 days (6522)
2026 (2016)
2025 (6745)
2024 (7136)
2023 (8390)
2022 (9456)
2021 (10000)
2020 (8988)
2019 (7615)
2018 (5870)
2017 (5190)
2016 (4536)
2015 (5935)
2014 (3674)
2013 (2500)
2012 (2628)
2011 (3194)
2010 (3259)
Location
Africa (95)
Alabama (10)
Arizona (32)
Asia (6163)
Australia (797)
California (2799)
Canada (694)
China (203)
Colorado (109)
Connecticut (129)
Delaware (116)
Europe (16776)
Florida (286)
Georgia (94)
Hawaii (1)
Idaho (11)
Illinois (235)
India (13)
Indiana (134)
Iowa (3)
Japan (152)
Kansas (20)
Kentucky (16)
Louisiana (12)
Maine (24)
Maryland (287)
Massachusetts (1720)
Michigan (47)
Minnesota (127)
Mississippi (1)
Missouri (24)
Montana (4)
Nebraska (1)
Nevada (25)
New Hampshire (20)
New Jersey (968)
New York (852)
North Carolina (327)
North Dakota (2)
Northern California (1479)
Ohio (53)
Oklahoma (3)
Oregon (5)
Pennsylvania (545)
Puerto Rico (1)
Rhode Island (6)
South America (149)
South Carolina (6)
Southern California (1096)
Tennessee (28)
Texas (340)
United States (9522)
Utah (179)
Virginia (39)
Washington D.C. (12)
Washington State (200)
Wisconsin (17)
Wyoming (1)
110,685 Results for "35".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
April 8, 2026
·
6 min read
Press Releases
Equillium Announces $35 Million Financing with RA Capital Management
March 13, 2026
·
5 min read
Press Releases
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement
April 7, 2026
·
7 min read
Press Releases
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
April 1, 2026
·
4 min read
Press Releases
Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months
April 30, 2026
·
7 min read
Press Releases
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
March 31, 2026
·
1 min read
Press Releases
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment
April 2, 2026
·
5 min read
Press Releases
Outpost Bio Raises $3.5 M Pre-Seed to Build Frontier Models for Human Microbiology
March 4, 2026
·
1 min read
Press Releases
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
March 10, 2026
·
6 min read
Manufacturing
Eli Lilly Commits $3.5B To Build Injectable Obesity Drug Plant in PA
The facility, which is part of Lilly’s $50 billion reshoring drive, will make obesity drugs such as tirzepatide and retatrutide when it starts operations in 2031.
February 2, 2026
·
2 min read
·
Nick Paul Taylor
1 of 11,069
Next
